• ROMA Score for Ovarian Cancer Risk Assessment
  • Toxoplasma IgG and IgM
  • Antinuclear Antibody (ANA), Body Fluid
  • MYC (8q24) Gene Rearrangement by FISH
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis, Li-Fraumeni Syndrome
  • Cancer Antigen (CA) 19-9, Serum
  • Chlorpromazine, Urine
  • Autoimmune Multi Biomarker Test for Rheumatoid Arthritis (Vectra® DA)
  • SSA (Ro) (ENA) Antibody, IgG
  • Beta-2 Glycoprotein 1 Antibody Panel (IgA, IgG, IgM)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 27- 29
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 27- 29
Medical Test

Additional ICD10
Access to Cancer Antigen (CA) 27- 29 is restricted.